II. Indications
- Ulcerative Colitis
- Crohns Disease
- Eosinophilic Esophagitis (off label, viscous suspension)
III. Mechanism
- Budesonide (oral, rectal) delivers local steroid primarily to Gastrointestinal Tract
- Each Budesonide formulation targets specific regions of the colon
- High first pass metabolism of Oral Budesonide significantly limits any Systemic Corticosteroid effects
IV. Dosing
- Background
- All budesonide forms are expensive ($700 to $1600 in 2023)
- Dosing is for adults unless otherwise specified
- Decrease dose in severe liver Impairment
- Budesonide Rectal Foam (Uceris Rectal Foam)
- Delivers 2 mg/actuation (with 14 doses per canister)
- Indicated for active disease in distal colon (induction)
- Affects only distal colon (last 15 to 20 cm)
- Dose
- Start 1 actuation (2 mg) twice daily (in am, and at bedtime) for 2 weeks
- Next 1 actuation (1 mg) once daily at bedtime for 4 weeks
- Budesonide Capsules (Enterocort EC)
- Available as 3 mg capsule
- May open capsules and sprinkle on soft food
- Indicated for active Crohns Disease in right colon (induction)
- Affects distal ileum and right colon
- Dosing: Adults and children age >= 9 years
- Take 9 mg orally daily for 8 weeks
- May repeat 8 week course if needed in adults
- May finish with taper dose at 6 mg for additional 2 weeks
- Dosing: Child age <8 years (off-label)
- Give 0.45 mg/kg up to 9 mg orally daily for 8 weeks
- Available as 3 mg capsule
- Budesonide Extended Release Tablets (Uceris XR Tablets)
- Indicated for active disease throughout the colon (induction)
- Dosing: Adults and children age >= 9 years
- Take 9 mg orally daily each morning for up to 8 weeks
- Budesonide Viscous Suspension
- Indicated in Eosinophilic Esophagitis
- Dose 2 mg orally daily
- Decrease to 1 mg orally daily in age <10 years or height <5 feet
V. Safety
- Pregnancy Category C
- Unknown safety in Lactation
VI. Resources
- Budesonide Capsule (DailyMed)
- Budesonide Extended Release Tablet (DailyMed)
- Budesonide Rectal Foam (DailyMed)
VII. References
- Hamilton (2020) Tarascon Pocket Pharmacopoeia
- (2022) Treatment of Mild to Moderate Ulcerative Colitis, Presc Lett, #350406
- (2023) Drugs for Inflammatory Bowel Disease, Med Lett Drug Ther 65: 105-12
Images: Related links to external sites (from Bing)
Related Studies
uceris (on 1/1/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
UCERIS 2 MG RECTAL FOAM | $10.92 per gram | |
UCERIS 9 MG ER TABLET | Generic | $28.48 each |